GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Apr 2016 01:01 PM
RNS
Total Voting Rights
30 Mar 2016 05:48 PM
RNS
Director/PDMR Shareholding
30 Mar 2016 12:00 PM
RNS
Notice of AGM
29 Mar 2016 05:23 PM
RNS
Director/PDMR Shareholding
29 Mar 2016 07:01 AM
RNS
Marketing approval received for Nucala® in Japan
22 Mar 2016 03:14 PM
RNS
Director/PDMR Shareholding
21 Mar 2016 04:09 PM
RNS
Director/PDMR Shareholding
21 Mar 2016 07:00 AM
RNS
Annual Report 2015 on Form 20-F
18 Mar 2016 02:58 PM
RNS
Director/PDMR Shareholding
17 Mar 2016 07:29 AM
RNS
Vestri Study Results GSK Advair in Children 4-11
17 Mar 2016 07:00 AM
RNS
Directorate Changes
17 Mar 2016 07:00 AM
RNS
Sir Andrew Witty to retire from GSK in March 2017
17 Mar 2016 07:00 AM
RNS
Publication of 2015 Annual Financial Report
11 Mar 2016 12:04 PM
RNS
Director/PDMR Shareholding
10 Mar 2016 02:40 PM
RNS
Director/PDMR Shareholding
07 Mar 2016 03:12 PM
RNS
Director/PDMR Shareholding
07 Mar 2016 07:00 AM
RNS
NEJM results of LABA Safety Study of Advair Diskus
01 Mar 2016 04:43 PM
RNS
Director/PDMR Shareholding- Replacement
01 Mar 2016 02:47 PM
RNS
Director/PDMR Shareholding
01 Mar 2016 02:43 PM
RNS
Director/PDMR Shareholding
01 Mar 2016 02:41 PM
RNS
Director/PDMR Shareholding
01 Mar 2016 02:41 PM
RNS
Director/PDMR Shareholding
01 Mar 2016 02:36 PM
RNS
Director/PDMR Shareholding
01 Mar 2016 02:33 PM
RNS
Director/PDMR Shareholding
01 Mar 2016 11:04 AM
RNS
Total Voting Rights
25 Feb 2016 11:23 AM
RNS
Director/PDMR Shareholding
24 Feb 2016 05:05 PM
RNS
PhII HIV prevention study results cabotegravir
23 Feb 2016 05:13 PM
RNS
PhII data on 2 drug long-acting injectable for HIV
22 Feb 2016 03:38 PM
RNS
ViiV completes transaction to acquire BMS Assets
18 Feb 2016 02:27 PM
RNS
Director/PDMR Shareholding
16 Feb 2016 05:22 PM
RNS
Director/PDMR Shareholding- Replacement
16 Feb 2016 05:20 PM
RNS
Director/PDMR Shareholding- Replacement
16 Feb 2016 04:16 PM
RNS
Director/PDMR Shareholding
16 Feb 2016 04:13 PM
RNS
Director/PDMR Shareholding
15 Feb 2016 05:58 PM
RNS
Director/PDMR Shareholding
15 Feb 2016 05:55 PM
RNS
Director/PDMR Shareholding
15 Feb 2016 10:55 AM
RNS
Director/PDMR Shareholding
12 Feb 2016 04:21 PM
RNS
Director/PDMR Shareholding
12 Feb 2016 04:20 PM
RNS
Director/PDMR Shareholding
12 Feb 2016 04:16 PM
RNS
Director/PDMR Shareholding
10 Feb 2016 01:00 PM
RNS
Director/PDMR Shareholding
03 Feb 2016 12:00 PM
RNS
Final Results
02 Feb 2016 09:46 AM
RNS
Director/PDMR Shareholding
01 Feb 2016 05:04 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 03:41 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 01:04 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 01:00 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 12:57 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 12:53 PM
RNS
Director/PDMR Shareholding
01 Feb 2016 12:47 PM
RNS
Total Voting Rights

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings